Announcements
- Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
- Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
- 1st Quarter Results
- Burning Rock Reports First Quarter 2024 Financial Results
- BNR Schedules 2024 Q1 Earnings Release on May 29
- Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
- BNR Announces ADS Ratio Change to Be Effective
- Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
- Burning Rock ADS Ratio Change
- BNR Publishes 2023 Annual Report on Form 20-F
More ▼
Key statistics
As of last trade, Burning Rock Biotech Ltd (6BU0:FRA) traded at 6.96, 24.29% above the 52 week low of 5.60 set on Jun 07, 2024.
52-week range
Open | 6.96 |
---|---|
High | 6.96 |
Low | 6.96 |
Bid | 5.62 |
Offer | 8.74 |
Previous close | 5.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.03m |
Free float | -- |
P/E (TTM) | -- |
Market cap | 78.29m USD |
EPS (TTM) | -64.76 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 08:59 BST.
More ▼